-+ 0.00%
-+ 0.00%
-+ 0.00%

MIRA PHARMACEUTICALS - SUBMITS PHASE 2A PROTOCOL FOR KETAMIR-2 IN CIPN TO IRB AFTER FDA REVIEW

路透·09/17/2026 12:30:02

登錄查看新聞詳情